VolitionRx Limited Announces Second Quarter 2017 Financial Results and Business Update

9 Aug 2017 - Yahoo News
ISNES, Belgium, Aug. 9, 2017 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the quarter ended June 30, 2017. Volition management will host a conference call to discuss these results and provide a further business update ...
usx:vnrx

---

VolitionRx Limited Schedules Second Quarter 2017 Earnings Conference Call and Business Update

3 Aug 2017 - Yahoo News
Conference call to take place Thursday, August 10, 2017 at 8:30 am Eastern time ISNES, Belgium , Aug. 3, 2017 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) today announced it will host a conference ...
usx:vnrx

---

VNRX: Large U.S. Study Comes Cheap, Could Support Asymptomatic FDA Filing

1 Aug 2017 - Yahoo News
VNRX is required to contribute just $3M (paid in equal quarterly installments over 3 years), with most of the funding borne by the study's main sponsor, the U.S. National Cancer Institute's (NCI) Early Detection Network (EDRN), which is the leading cancer research organization in the U.S. The Great ...
usx:vnrx

---

Cancer test group VolitionRx"s US trial is huge result, says chief executive - Proactive Investors USA & Canada

31 Jul 2017 - Proactive Investors USA & Canada

usx:vnrx

---

Health Care Sector Update for 07/20/2017: VNRX,SRPT,CFRX

20 Jul 2017 - Nasdaq
Top Health Care StocksTop Health Care Stocks JNJ 1 1 JNJ 1 1 PFE 0 04 PFE 0 04 ABT 3 1 ABT 3 1 MRK 0 7 MRK 0 7 AMGN 0 2 AMGN 0 2 Health care stocks finishing on top of Thursday s leaderboard with the NYSE Health Care Index NYP climbing almost 0 9 while shares of health
usx:cfrx usx:vnrx

---

VolitionRx Limited to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute

19 Jul 2017 - Yahoo News
NYSE MKT: VNRX), announced it will host a conference call tomorrow, July 20 at 8:30 AM U.S. Eastern Time to discuss its participation in a large multi-center clinical study with the Great Lakes New England Clinical Validation Center funded by the U.S. National Cancer Institute's (NCI) Early Detection ...
usx:vnrx

---

Volition America, Inc. Announces a Colorectal Cancer Screening Trial containing approximately 13,500 Subjects in Collaboration with the Early Detection Research Network of the U.S. National Cancer Institute

18 Jul 2017 - Yahoo News
NYSE MKT: VNRX), has signed an agreement to participate in a large multi-center clinical study with the Great Lakes New England Clinical Validation Center funded by the U.S. National Cancer Institute's (NCI) Early Detection Research Network (EDRN). The clinical study will provide approximately 13,500 ...
usx:vnrx

---

Volition to Present at the EuropaColon Advocacy Masterclass and Exhibit at the European Society for Medical Oncology Gastrointestinal Cancer Congress

30 Jun 2017 - Yahoo News
ISNES, Belgium, June 30, 2017 /PRNewswire/ -- VolitionRx Limited (NYSE MKT: VNRX) today announced it will be presenting at the EuropaColon Advocacy Masterclass and will be exhibiting at the European Society for Medical Oncology Congress on Gastrointestinal Cancer (ESMO GI). The organisation's annual ...
usx:vnrx

---

VNRX: Replacing Triage Assays Could Be Non-Event

29 Jun 2017 - Yahoo News
By Brian Marckx, CFA NYSE:VNRX Replacing Triage Assays: May Only Result in Relatively Short Delay - Could Be a Non-Event In a brief June 27th press release VolitionRx (NYSE:VNRX) noted that the company's ...
usx:vnrx

---

VolitionRx Limited Corrects an Earlier Announcement

27 Jun 2017 - Yahoo News
ISNES, Belgium, June 27, 2017 /PRNewswire/ -- VolitionRx Limited (NYSE MKT: VNRX) today has issued corrections to certain statements made in the press release issued by the Company on May 9, 2017 regarding the Company's Nu.Q™ Colorectal Cancer Screening Triage Test. Due to the Company's administrative ...
usx:vnrx

---